# PERRIGO Co plc

> Clarifo company profile — qualitative business description generated from
> the company's filings. Financial statements, charts and ratios are
> available on Clarifo (https://www.clarifo.com/en/companies/PERRIGO Co plc).

## Overview

Perrigo Co plc is a consumer self-care company focused on over-the-counter health and wellness products sold through retail and pharmacy channels. Its portfolio spans store-brand and branded products across North America and Europe, including infant formula, upper respiratory, nutrition, women’s health, oral care, skin care, and other everyday self-care categories.

## Products & services

• Store-brand OTC self-care products
• Branded consumer health products
• Infant formula and nutrition products
• Upper respiratory remedies
• Women’s health products
• Skin care and topical treatments
• Oral care and wellness solutions

- **Store-brand self-care** (45%) — Private-label OTC health products sold through retail and pharmacy customers.
- **Branded consumer health** (25%) — Consumer health brands sold under Perrigo-owned names in key markets.
- **Infant formula and nutrition** (15%) — Infant formula and related nutrition products sold in North America and other markets.
- **Women’s health and contraception** (5%) — Products such as emergency contraception and related women’s health items.
- **Skin care and topical treatments** (5%) — Products including skin care, wound care, and topical consumer health items.
- **Other self-care categories** (5%) — Additional OTC and wellness categories such as oral care and upper respiratory.

- Store-brand OTC self-care products
- Branded consumer health products
- Infant formula and nutrition products
- Upper respiratory remedies
- Women’s health products
- Skin care and topical treatments
- Oral care and wellness solutions

## Customers

Perrigo sells primarily to large retail chains, mass merchants, pharmacies, and other consumer health distributors that stock store-brand and branded OTC products. End demand comes from consumers seeking affordable, accessible self-care products without a prescription, while Perrigo’s customers buy to fill shelf space, support category breadth, and offer value-priced alternatives. The company also serves a small number of large customers, with Walmart representing a significant share of sales in the latest reported year.

- **Large retail and mass merchant chains** (primary) — They buy store-brand OTC products and branded consumer health items to support shelf assortment and value pricing.
- **Pharmacy and drugstore channels** (primary) — They purchase OTC remedies and wellness products for prescription-adjacent and self-care aisles.
- **Consumer health distributors** (secondary) — They source branded and private-label products for regional or specialty retail distribution.
- **End consumers** (primary) — They buy Perrigo-branded and store-brand products for everyday self-care needs and affordability.

- Large retail chains and mass merchants buy private-label OTC products
- Pharmacies and drugstores buy branded and store-brand self-care items
- Consumers choose Perrigo products for affordability and convenience
- Walmart is a significant customer and key channel partner
- Customers value category breadth, reliable supply, and product innovation

## Geography

Perrigo’s business is concentrated in North America and Europe, with those regions forming the core of its consumer self-care platform. North America is especially important for store-brand leadership and products such as Opill and Mederma, while Europe is anchored by brands including Compeed, ellaOne, Solpadeine, Jungle Formula, and ACO. The company’s manufacturing, sourcing, and regulatory footprint spans multiple countries, so product availability and compliance depend on regional supply chains and local market rules.

- **North America** (55%) — Management describes North America as a primary region, but no exact revenue split was disclosed.
- **Europe** (45%) — Management describes Europe as a primary region, but no exact revenue split was disclosed.

- North America is a core market for store-brand OTC products
- Europe is a major branded self-care market for Perrigo
- Regional product mixes differ by regulation and consumer habits
- Manufacturing and sourcing are spread across multiple countries
- Supply chain reliability matters because products are sold in many markets

## Strategy

Perrigo’s strategy centers on consumer-led innovation, stronger branded and store-brand demand generation, and a more efficient global supply chain. The company also emphasizes portfolio focus, with capital and management attention directed toward categories and brands that can scale across geographies and channels. Its operating model is built to support value-priced self-care products while expanding adjacent categories and new product launches.

- **Consumer-led innovation and line extensions** (short-term) — Keeps the portfolio relevant and supports shelf space with retail customers.
- **Portfolio focus on core self-care brands** (medium-term) — Concentrates resources on categories with stronger strategic fit and scale.
- **Supply chain and operating model efficiency** (medium-term) — A more efficient network supports service levels, cost control, and resilience.
- **Infant formula footprint optimization** (short-term) — Manufacturing and quality improvements are intended to support this business line.

- Focus investment behind key brands and higher-priority categories
- Use consumer-led innovation to refresh and extend product lines
- Strengthen store-brand and branded customer partnerships
- Improve supply chain efficiency and operating agility
- Expand into adjacent categories, geographies, and channels

## Risks

Perrigo faces the usual consumer health risks of competition, regulation, product quality, and raw-material volatility, but its business is also exposed to retail concentration and supply-chain disruption. Because many products are sold through a small number of large customers and manufactured through a global network, service failures, recalls, or logistics interruptions can quickly affect sales and reputation. The company also carries meaningful goodwill and impairment risk tied to category performance and portfolio changes.

- **Customer concentration** [high] — A small number of large retailers account for a meaningful share of sales, so lost shelf space or weaker terms can hurt revenue.
- **Supply chain disruption** [high] — Global sourcing and manufacturing create exposure to plant outages, logistics issues, labor shortages, and geopolitical events.
- **Regulatory and product quality risk** [high] — OTC and infant formula products operate in regulated categories where compliance or safety issues can stop shipments or damage trust.
- **Raw material and input cost volatility** [medium] — Ingredient and packaging costs can move quickly and are difficult to fully pass through in retail channels.
- **Goodwill impairment** [high] — The company has large goodwill balances and uses impairment testing that can produce non-cash charges when expectations change.

- Large retail customers can pressure pricing and terms
- Supply-chain disruption can interrupt manufacturing and delivery
- Regulatory and quality failures can block sales or trigger recalls
- Raw-material and freight cost swings affect product economics
- Goodwill and intangible assets are exposed to impairment

## Accounting

Perrigo’s reported results are sensitive to goodwill impairment testing, especially where category outlooks, share price, and cash-flow assumptions change. The company also has judgment-heavy areas around inventory, provisions, customer-related reserves, and held-for-sale accounting when businesses are divested or reviewed. Because it sells through retailers and operates globally, timing of revenue, returns, and supply-chain-related estimates can affect quarterly comparability.

- **Goodwill impairment** — CSCA and CSCI goodwill balances and earnings
- **Held-for-sale classification** — Asset presentation and disposal gains/losses
- **Inventory and reserves** — Gross margin and working capital
- **Revenue recognition and customer allowances** — Quarterly sales comparability

- Goodwill impairment testing can create large non-cash charges
- Held-for-sale accounting affects assets and disposal presentation
- Inventory and reserves matter in OTC and infant formula categories
- Revenue timing and returns can affect quarterly comparability
- Estimates for contingencies and customer-related reserves are judgmental

---

*Last updated: 2026-04-29T04:45:56.336217+00:00*